Linnaeus Bioscience is a company that focuses on the development and commercialization of technologies that support drug discovery. Its bacterial cytological profiling (BCP) platform helps to discover new compounds to treat microbial disease and bacterial infections. The company aims to assist the pharmaceutical industry in developing a pipeline of molecules to address the growing problem of microbial infection and drug resistance.